CoreWeave

CoreWeave's May 2026 earnings will test whether it can convert its $66.8B backlog into revenue, maintain capital efficiency, and diversify beyond concentrated customers.

$CRWV shares bounce back Thursday following platform expansion. Stock up 176% annually, trades near $115 with $124 price target.

Anthropic secures multi-year compute capacity deal with CoreWeave, validating specialized AI infrastructure providers as essential to the generative AI ecosystem.

CoreWeave, a GPU data center provider with tens of billions in multiyear contracts from OpenAI and Meta, positions itself as an infrastructure play despite 2025 losses of $606M on $5.1B revenue.

CoreWeave stock surged 8.37% Monday as four analysts raised price targets, citing Meta's $21B deal and Anthropic partnership alongside successful pricing increases.

Nebius and CoreWeave compete for AI datacenter dominance as LLM demand soars. Nebius secured $46B in Microsoft and Meta deals, while CoreWeave pursues specialized GPU infrastructure positioning.

CoreWeave faces bullish analyst sentiment on AI demand, but $21 billion debt and insider selling mask significant financial risks that could derail growth prospects.

CoreWeave, Dell, and Diamondback insiders sold $100M+ in 2026, but sales are declining, aligned with buybacks, or follow private equity timelines.

CoreWeave lands multi-year GPU deal with Perplexity amid 50% stock decline, signaling continued AI infrastructure demand despite market concerns about spending slowdown.

Class action filed against CoreWeave ($CRWV) alleging executives made false statements about operational capabilities and customer demand fulfillment between March-December 2025. Lead plaintiff deadline: March 13, 2026.

CoreWeave posts 168% revenue growth to $5.1B with $66.8B backlog, guiding to $12-13B 2026 revenue, backed by IBM and OpenAI partnerships.

CoreWeave hit $5.1B revenue in 2025, up 168%, but swung to $46M operating loss amid $1.2B interest expenses and heavy Nvidia dependence.

CoreWeave faces securities fraud lawsuit alleging misstatements about customer demand capacity, supplier reliance, and financial risks during March-December 2025 class period.

Rosen Law Firm files class action against $BSX over alleged false statements regarding U.S. Electrophysiology segment sustainability, resulting in earnings miss and weak guidance.

CoreWeave faces securities class action over false demand statements and concealed supplier concentration risk. March 13, 2026 deadline for affected investors.

CoreWeave's Perplexity deal validates shift from AI training to inference workloads. $66.8B backlog and $30-35B 2026 capex support analyst targets of $124.34.

Class action lawsuit alleges CoreWeave made materially false statements about demand and supplier risks between March-December 2025. Lead plaintiff deadline: March 13, 2026.

CoreWeave ($CRWV) faces securities class action lawsuit alleging false demand statements and understated supplier risks. Lead plaintiff deadline: March 13, 2026.

$CRWV faces class action suit alleging misleading statements about customer demand and vendor concentration risks. Investors who bought shares between March-December 2025 can join lawsuit.

CoreWeave investors have until March 13, 2026, to join securities fraud class action alleging misrepresented demand and concealed construction delays that triggered 16% stock decline.